Cerity Partners LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cerity Partners LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$250,919
-22.8%
1,578
-31.3%
0.00%0.0%
Q2 2023$324,934
-75.7%
2,297
-71.0%
0.00%
-66.7%
Q1 2023$1,334,927
+331.1%
7,929
+333.5%
0.00%
+50.0%
Q4 2022$309,669
-3.8%
1,829
+6.3%
0.00%
-50.0%
Q3 2022$322,000
+21.1%
1,720
+5.1%
0.00%
+33.3%
Q2 2022$266,000
-11.6%
1,636
+2.4%
0.00%
-40.0%
Q1 2022$301,000
-4.7%
1,597
+34.0%
0.01%0.0%
Q4 2021$316,0001,1920.01%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders